Myasthenia gravis experimentally induced with muscle-specific kinase

Kazuhiro Shigemoto, Sachiho Kubo, Chen Jie, Naohito Hato, Yasuhito Abe, Norifumi Ueda, Naoto Kobayashi, Kenji Kameda, Katsumi Mominoki, Atsuo Miyazawa, Akihito Ishigami, Seiji Matsuda, Naoki Maruyama

Research output: Chapter in Book/Report/Conference proceedingConference contribution

27 Citations (Scopus)

Abstract

Here we present the first evidence that muscle-specific kinase (MuSK) antigen can cause myasthenia in animals. MuSK is expressed at the postsynaptic membranes of neuromuscular junctions (NMJ) and forms complexes with acetylcholine receptors (AChR) and rapsyn. MuSK is activated by agrin, which is released from motoneurons, and induces AChR clustering and subsequent formation of NMJ in embryos. Notably, autoantibodies against MuSK were found in a proportion of patients with generalized myasthenia gravis (MG) but without the characteristic AChR autoantibodies. However, MuSK autoantibodies had no known pathogenic potential, and animals immunized with purified MuSK proteins did not develop MG in former studies. In contrast, we have now injected rabbits with MuSK ectodomain protein in vivo and evoked a MG-like muscle weakness with a reduction of AChR clustering at the NMJ. Our results showed that MuSK is required for maintenance of synapses and that interference with that function by MuSK antibodies causes myasthenic weakness. In vitro, AChR clustering in myotubes is induced by agrin and agrin-independent inducers, which do not activate MuSK. Neither the receptor nor the activation mechanisms of AChR clustering induced by agrin-independent inducers has been identified with certainty, but MuSK autoantibodies in myasthenic animals inhibited both agrin and agrin-independent AChR clustering. MuSK plays multiple roles in pre-patterning of the postsynaptic membrane before innervation and formation of NMJ in embryos. Some of these mechanisms may also participate in the maintenance of mature NMJ. This model system would provide new knowledge about the molecular pathogenesis of MG and MuSK functions in mature NMJ.

Original languageEnglish
Title of host publicationAnnals of the New York Academy of Sciences
Pages93-98
Number of pages6
Volume1132
DOIs
Publication statusPublished - Jun 2008

Publication series

NameAnnals of the New York Academy of Sciences
Volume1132
ISSN (Print)00778923
ISSN (Electronic)17496632

Fingerprint

Myasthenia Gravis
Muscle
Phosphotransferases
Agrin
Muscles
Cholinergic Receptors
Neuromuscular Junction
Cluster Analysis
Autoantibodies
Muscle Weakness
Animals
Protein Kinases
Embryonic Structures
Maintenance
Membranes
Skeletal Muscle Fibers
Motor Neurons
Synapses

Keywords

  • Acetylcholine receptor (AChR)
  • Congenital myasthenic syndromes (CMS)
  • Experimental autoimmune MG (EAMG)
  • Muscle-specific kinase (MuSK)
  • Myasthenia gravis (MG)
  • Neuromuscular junction (NMJ)

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Shigemoto, K., Kubo, S., Jie, C., Hato, N., Abe, Y., Ueda, N., ... Maruyama, N. (2008). Myasthenia gravis experimentally induced with muscle-specific kinase. In Annals of the New York Academy of Sciences (Vol. 1132, pp. 93-98). (Annals of the New York Academy of Sciences; Vol. 1132). https://doi.org/10.1196/annals.1405.002

Myasthenia gravis experimentally induced with muscle-specific kinase. / Shigemoto, Kazuhiro; Kubo, Sachiho; Jie, Chen; Hato, Naohito; Abe, Yasuhito; Ueda, Norifumi; Kobayashi, Naoto; Kameda, Kenji; Mominoki, Katsumi; Miyazawa, Atsuo; Ishigami, Akihito; Matsuda, Seiji; Maruyama, Naoki.

Annals of the New York Academy of Sciences. Vol. 1132 2008. p. 93-98 (Annals of the New York Academy of Sciences; Vol. 1132).

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Shigemoto, K, Kubo, S, Jie, C, Hato, N, Abe, Y, Ueda, N, Kobayashi, N, Kameda, K, Mominoki, K, Miyazawa, A, Ishigami, A, Matsuda, S & Maruyama, N 2008, Myasthenia gravis experimentally induced with muscle-specific kinase. in Annals of the New York Academy of Sciences. vol. 1132, Annals of the New York Academy of Sciences, vol. 1132, pp. 93-98. https://doi.org/10.1196/annals.1405.002
Shigemoto K, Kubo S, Jie C, Hato N, Abe Y, Ueda N et al. Myasthenia gravis experimentally induced with muscle-specific kinase. In Annals of the New York Academy of Sciences. Vol. 1132. 2008. p. 93-98. (Annals of the New York Academy of Sciences). https://doi.org/10.1196/annals.1405.002
Shigemoto, Kazuhiro ; Kubo, Sachiho ; Jie, Chen ; Hato, Naohito ; Abe, Yasuhito ; Ueda, Norifumi ; Kobayashi, Naoto ; Kameda, Kenji ; Mominoki, Katsumi ; Miyazawa, Atsuo ; Ishigami, Akihito ; Matsuda, Seiji ; Maruyama, Naoki. / Myasthenia gravis experimentally induced with muscle-specific kinase. Annals of the New York Academy of Sciences. Vol. 1132 2008. pp. 93-98 (Annals of the New York Academy of Sciences).
@inproceedings{326f380c96b4421f85ebb9fdf7b71b7a,
title = "Myasthenia gravis experimentally induced with muscle-specific kinase",
abstract = "Here we present the first evidence that muscle-specific kinase (MuSK) antigen can cause myasthenia in animals. MuSK is expressed at the postsynaptic membranes of neuromuscular junctions (NMJ) and forms complexes with acetylcholine receptors (AChR) and rapsyn. MuSK is activated by agrin, which is released from motoneurons, and induces AChR clustering and subsequent formation of NMJ in embryos. Notably, autoantibodies against MuSK were found in a proportion of patients with generalized myasthenia gravis (MG) but without the characteristic AChR autoantibodies. However, MuSK autoantibodies had no known pathogenic potential, and animals immunized with purified MuSK proteins did not develop MG in former studies. In contrast, we have now injected rabbits with MuSK ectodomain protein in vivo and evoked a MG-like muscle weakness with a reduction of AChR clustering at the NMJ. Our results showed that MuSK is required for maintenance of synapses and that interference with that function by MuSK antibodies causes myasthenic weakness. In vitro, AChR clustering in myotubes is induced by agrin and agrin-independent inducers, which do not activate MuSK. Neither the receptor nor the activation mechanisms of AChR clustering induced by agrin-independent inducers has been identified with certainty, but MuSK autoantibodies in myasthenic animals inhibited both agrin and agrin-independent AChR clustering. MuSK plays multiple roles in pre-patterning of the postsynaptic membrane before innervation and formation of NMJ in embryos. Some of these mechanisms may also participate in the maintenance of mature NMJ. This model system would provide new knowledge about the molecular pathogenesis of MG and MuSK functions in mature NMJ.",
keywords = "Acetylcholine receptor (AChR), Congenital myasthenic syndromes (CMS), Experimental autoimmune MG (EAMG), Muscle-specific kinase (MuSK), Myasthenia gravis (MG), Neuromuscular junction (NMJ)",
author = "Kazuhiro Shigemoto and Sachiho Kubo and Chen Jie and Naohito Hato and Yasuhito Abe and Norifumi Ueda and Naoto Kobayashi and Kenji Kameda and Katsumi Mominoki and Atsuo Miyazawa and Akihito Ishigami and Seiji Matsuda and Naoki Maruyama",
year = "2008",
month = "6",
doi = "10.1196/annals.1405.002",
language = "English",
isbn = "9781573316873",
volume = "1132",
series = "Annals of the New York Academy of Sciences",
pages = "93--98",
booktitle = "Annals of the New York Academy of Sciences",

}

TY - GEN

T1 - Myasthenia gravis experimentally induced with muscle-specific kinase

AU - Shigemoto, Kazuhiro

AU - Kubo, Sachiho

AU - Jie, Chen

AU - Hato, Naohito

AU - Abe, Yasuhito

AU - Ueda, Norifumi

AU - Kobayashi, Naoto

AU - Kameda, Kenji

AU - Mominoki, Katsumi

AU - Miyazawa, Atsuo

AU - Ishigami, Akihito

AU - Matsuda, Seiji

AU - Maruyama, Naoki

PY - 2008/6

Y1 - 2008/6

N2 - Here we present the first evidence that muscle-specific kinase (MuSK) antigen can cause myasthenia in animals. MuSK is expressed at the postsynaptic membranes of neuromuscular junctions (NMJ) and forms complexes with acetylcholine receptors (AChR) and rapsyn. MuSK is activated by agrin, which is released from motoneurons, and induces AChR clustering and subsequent formation of NMJ in embryos. Notably, autoantibodies against MuSK were found in a proportion of patients with generalized myasthenia gravis (MG) but without the characteristic AChR autoantibodies. However, MuSK autoantibodies had no known pathogenic potential, and animals immunized with purified MuSK proteins did not develop MG in former studies. In contrast, we have now injected rabbits with MuSK ectodomain protein in vivo and evoked a MG-like muscle weakness with a reduction of AChR clustering at the NMJ. Our results showed that MuSK is required for maintenance of synapses and that interference with that function by MuSK antibodies causes myasthenic weakness. In vitro, AChR clustering in myotubes is induced by agrin and agrin-independent inducers, which do not activate MuSK. Neither the receptor nor the activation mechanisms of AChR clustering induced by agrin-independent inducers has been identified with certainty, but MuSK autoantibodies in myasthenic animals inhibited both agrin and agrin-independent AChR clustering. MuSK plays multiple roles in pre-patterning of the postsynaptic membrane before innervation and formation of NMJ in embryos. Some of these mechanisms may also participate in the maintenance of mature NMJ. This model system would provide new knowledge about the molecular pathogenesis of MG and MuSK functions in mature NMJ.

AB - Here we present the first evidence that muscle-specific kinase (MuSK) antigen can cause myasthenia in animals. MuSK is expressed at the postsynaptic membranes of neuromuscular junctions (NMJ) and forms complexes with acetylcholine receptors (AChR) and rapsyn. MuSK is activated by agrin, which is released from motoneurons, and induces AChR clustering and subsequent formation of NMJ in embryos. Notably, autoantibodies against MuSK were found in a proportion of patients with generalized myasthenia gravis (MG) but without the characteristic AChR autoantibodies. However, MuSK autoantibodies had no known pathogenic potential, and animals immunized with purified MuSK proteins did not develop MG in former studies. In contrast, we have now injected rabbits with MuSK ectodomain protein in vivo and evoked a MG-like muscle weakness with a reduction of AChR clustering at the NMJ. Our results showed that MuSK is required for maintenance of synapses and that interference with that function by MuSK antibodies causes myasthenic weakness. In vitro, AChR clustering in myotubes is induced by agrin and agrin-independent inducers, which do not activate MuSK. Neither the receptor nor the activation mechanisms of AChR clustering induced by agrin-independent inducers has been identified with certainty, but MuSK autoantibodies in myasthenic animals inhibited both agrin and agrin-independent AChR clustering. MuSK plays multiple roles in pre-patterning of the postsynaptic membrane before innervation and formation of NMJ in embryos. Some of these mechanisms may also participate in the maintenance of mature NMJ. This model system would provide new knowledge about the molecular pathogenesis of MG and MuSK functions in mature NMJ.

KW - Acetylcholine receptor (AChR)

KW - Congenital myasthenic syndromes (CMS)

KW - Experimental autoimmune MG (EAMG)

KW - Muscle-specific kinase (MuSK)

KW - Myasthenia gravis (MG)

KW - Neuromuscular junction (NMJ)

UR - http://www.scopus.com/inward/record.url?scp=45249083240&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=45249083240&partnerID=8YFLogxK

U2 - 10.1196/annals.1405.002

DO - 10.1196/annals.1405.002

M3 - Conference contribution

C2 - 18096854

AN - SCOPUS:45249083240

SN - 9781573316873

VL - 1132

T3 - Annals of the New York Academy of Sciences

SP - 93

EP - 98

BT - Annals of the New York Academy of Sciences

ER -